The Maharashtra's Food and Drugs Administration (FDA) has lodged a First Information Report (FIR) against e-commerce giant Snapdeal CEO Kunal Bahl for the sale of prescription drugs online. The move came after the FDA raided the premises of Jasper Infotech, which owns Snapdeal, at Goregoan in Mumbai, about two weeks ago. Snapdeal said that it will assist the FDA team's investigation.
A company spokesperson said, "Upon being notified of any such products, we delist the products and take appropriate action against such seller. In this matter, we are assisting FDA team in this investigation, we will continue to do so. Snapdeal acts as an intermediary between the seller and buyer of the products listed on the platform. We educate sellers on consequences of selling inappropriate products, at times sellers end up listing such products. We have already delisted the products and sellers and also stopped payment, in addition to providing all information to the FDA team as required by them."